UCLA David Geffen School of Medicine, University of California, 4644 Lincoln Blvd., Suite 409, Marina del Rey, Los Angeles, CA, 90292, USA,
Diabetes Ther. 2013 Dec;4(2):239-56. doi: 10.1007/s13300-013-0039-6. Epub 2013 Oct 5.
Elderly patients with type 2 diabetes mellitus (T2DM) are a rapidly emerging population that presents unique clinical challenges. This diverse patient group can differ widely in terms of physical and mental status, which can increase their risk of complications including hypoglycemia, falls, and depression. These factors can negatively impact their glycemic control, safety, and quality of life. The risk of hypoglycemic events is elevated among elderly patients with diabetes. In many cases, these events are related to antidiabetic therapy and the pursuit of strict glycemic control. Fear of a hypoglycemic episode, on the part of the patient and/or healthcare provider, is another major barrier to achieving glycemic control. Hypoglycemic events, even in the absence of awareness of the event (asymptomatic), can have negative consequences. To help manage these risks, several national and international organizations have proposed guidelines to address individualized treatment goals for older adults with diabetes. This article reviews current treatment guidelines for setting glycemic targets in elderly patients with T2DM, and discusses the role of emerging treatment options in this patient population.
患有 2 型糖尿病(T2DM)的老年患者是一个迅速增长的群体,他们面临着独特的临床挑战。这个多样化的患者群体在身体和精神状况方面可能存在很大差异,这会增加他们出现低血糖、跌倒和抑郁等并发症的风险。这些因素会对他们的血糖控制、安全性和生活质量产生负面影响。老年糖尿病患者发生低血糖事件的风险较高。在许多情况下,这些事件与降糖治疗和严格的血糖控制有关。患者和/或医疗保健提供者对低血糖事件的恐惧是实现血糖控制的另一个主要障碍。即使没有意识到低血糖事件(无症状),低血糖事件也会产生负面影响。为了帮助管理这些风险,一些国家和国际组织已经提出了指导方针,以解决老年糖尿病患者的个体化治疗目标。本文回顾了目前针对 T2DM 老年患者设定血糖目标的治疗指南,并讨论了新兴治疗方案在这一患者群体中的作用。